Skip to main content
. Author manuscript; available in PMC: 2019 Aug 18.
Published in final edited form as: Mol Psychiatry. 2019 Feb 18;25(11):2932–2941. doi: 10.1038/s41380-019-0375-7

Table 1. Subject characteristics.

High AD pathology indicates classification of moderate or high pathology on NIA/Reagan criteria, Low AD pathology indicates classification of no or low pathology using NIA/Reagan criteria. Low AD pathology post mortem in subjects with a diagnosis of AD in life indicates clinical misdiagnosis.

AD Pathology (NIA/Reagan) Low Low High High
Clinical diagnosis Cognitively Normal Alzheimer’s Cognitively Normal Alzheimer’s
N 69 14 71 55
Age at death: mean (S.D.) 87∙8 (6∙0) 92∙9 (4∙5) 89∙9 (6∙5) 90∙7 (5∙1)
Female sex: n (%) 23 (33%) 7 (50%) 20 (28%) 19 (35%)
APOE ε4: n (%) 5 (7%) 2 (14%) 23 (32%) 15 (27%)
Education years: mean (S.D.) 14∙5 (2∙6) 14∙6 (2∙4) 14∙5 (2∙4) 15∙1 (2∙8)
Presence of Lewy bodies: n (%) 9 (13%) 6 (43%) 9 (13%) 15 (27%)
Presence of gross infarcts: n (%) 19 (28%) 8 (57%) 30 (42%) 25 (45%)
Presence of microinfarcts: n (%) 15 (22%) 4 (29%) 23 (32%) 20 (36%)